Coronavirus BRIEFING
Supported by Essilor

Crisis Response Tactics

Paxlovid Showed Benefit for Some Long COVID-19 Cases

By Staff
Tuesday, January 7, 2025 6:09 AM Extended courses of nirmatrelvir/ritonavir (Paxlovid) showed benefit for a few long COVID patients in a case series.

Sick Season Is in Full Force: Here's What the Latest CDC Figures Show

By Staff
Monday, January 6, 2025 6:09 AM The holidays came with a side of flu for many Americans, with 40 states reporting high or very high levels of illness last week, according to the latest government health data. "A lot of flu out there," said the CDC's Carrie Reed, PhD.

ABIM Revokes Certification of Another Doctor Who Made Controversial COVID Claims

By Staff
Friday, January 3, 2025 6:09 AM The American Board of Internal Medicine (ABIM) revoked the board certification of Peter McCullough, MD, MPH, a cardiologist who promoted controversial views about COVID-19.

U.S. FDA Revokes Authorization for Four COVID Antibody Drugs

By Staff
Monday, December 30, 2024 8:05 AM The U.S. Food and Drug Administration has revoked the emergency use authorization for four COVID-19 antibody-based drugs, including those from Eli Lilly and Regeneron.

U.S. Government Accountability Office Releases Vaccine Injury Claims Analysis

By Staff
Monday, December 30, 2024 6:09 AM Vaccine injury claims related to COVID vaccines were 27 times higher than claims during the first decade of the Countermeasures Injury Compensation Program, with just 3% eligible for compensation, according to a U.S. Government Accountability Office analysis.

Trump Transition Team Plans Immediate WHO Withdrawal, Expert Says

By Staff
Thursday, December 26, 2024 8:05 AM WASHINGTON—Members of Donald Trump's presidential transition team are laying the groundwork for the United States to withdraw from the World Health Organization on the first day of his second term, according to a health law expert familiar with the discussions.

Are You Contagious? Check When You're Most Likely to Spread COVID, the Flu and Other Common Illnesses

By Staff
Thursday, December 26, 2024 6:09 AM This is when people are most likely to spread COVID, the flu and other illnesses. But how long are you contagious?

Younger People and Long COVID: Underreported, Undertreated

By Staff
Monday, December 23, 2024 8:05 AM John Bolecek, 41, of Richmond, Virginia, was diagnosed with long COVID in May of 2022. While his acute infection was mild, once everyone else in his family had recovered, the heavy fatigue he experienced from the start has never lifted.

U.S. Sees Rise in Life Expectancy After Pandemic Decline

By Staff
Friday, December 20, 2024 7:59 AM COVID-19 continues to retreat from being a top cause of death in the U.S., and in turn, life expectancy last year rebounded further toward pre-pandemic longevity.

Long COVID Symptoms Improve With Outpatient Intervention

By Staff
Friday, December 20, 2024 6:09 AM Self-reported physical function was better for long COVID patients after a brief outpatient program based on cognitive and behavioral therapy, a pragmatic trial in Norway showed.

What’s Behind Wild State-by-State Variations in Long COVID?

By Staff
Thursday, December 19, 2024 8:05 AM Long COVID rates are significantly higher in the South, Midwest, and West than in New England and the Northeast—with rates two to three times higher in some cases, a new federal study showed.

Prevalence of Post–COVID-19 Condition Among Adults

By Staff
Wednesday, December 18, 2024 6:09 AM About 8 percent of U.S. adults have had long COVID, survey data showed. Head over to MedPage Today to read more about it.

Managing Return-to-Work Barriers for People With Long COVID

By Staff
Tuesday, December 17, 2024 7:59 AM Long COVID can have an enormous impact on people’s ability to work, particularly if they do not have workplace accommodations and support. Although some patients experience symptoms so severe that they cannot work under any conditions, medical providers and employers can help ensure many patients with long COVID can stay in the workforce.

Self-Replicating mRNA Vaccine for COVID Prevention

By Staff
Monday, December 16, 2024 8:05 AM Europe's Committee for Medicinal Products for Human Use (CHMP) recommended granting marketing authorization for two drugs for preventing COVID-19: a monoclonal antibody called Kavigale (sipavibart) and a self-amplifying mRNA vaccine known as Kostaive (zapomeran). The recommendations are now in line for approval by the European Commission.

Flu and COVID-19 Activity Are on the Rise

By Staff
Monday, December 16, 2024 6:09 AM COVID-19 activity is beginning to increase from low levels in some areas of the nation. Seasonal influenza activity continues to increase across the country. RSV activity is moderate and continues to increase in most areas of the United States, particularly in young children.